Trial · NCT02666664
Results by group178
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 178
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Placebo | Any TEAE | 78.7 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Bempedoic Acid | Any TEAE | 78.5 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Placebo | Any serious TEAE | 14.0 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Bempedoic Acid | Any serious TEAE | 14.5 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Placebo | Any fatal TEAE | 0.3 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Bempedoic Acid | Any fatal TEAE | 0.9 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Placebo | Any TEAE leading to discontinuation of study drug | 7.1 | percentage of participants | |
| Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) | Bempedoic Acid | Any TEAE leading to discontinuation of study drug | 10.9 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any adjudicated major clinical event | 5.7 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any adjudicated major clinical event | 4.6 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any TE death from cardiovascular causes | 0.1 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any TE death from cardiovascular causes | 0.4 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any nonfatal myocardial infarction | 1.8 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any nonfatal myocardial infarction | 1.3 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any nonfatal stroke | 0.3 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any nonfatal stroke | 0.3 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any coronary revascularization | 3.2 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any coronary revascularization | 2.6 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Placebo | Any hospitalization for unstable angina | 1.5 | percentage of participants | |
| Percentage of Participants With Adjudicated Major Adverse Cardiovascular Event | Bempedoic Acid | Any hospitalization for unstable angina | 0.9 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02666664/results